Nuclear Medicine, Nuclear Cardiology · Kansas City, MO
NPI
1134187339
Since 2006
Specialty
Nuclear Medicine, Nuclear Cardiology
Code 207UN0901X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4330 Wornall Rd, Suite 2000
Kansas City, MO, 64111
Phone (816) 931-1883
Groups this clinician bills Medicare through
Medicare paid, 2024
$93K
2,918 services
Medicare patients, 2024
1,221
Average age 75
Drug cost, 2024
$2.7M
8,573 prescriptions
Company payments, 2025
$20K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James H O'Keefe Jr. was code 93018 (electrocardiogram), 451 times for 449 patients. In total James H O'Keefe Jr. billed 2,918 services in 39 codes, and Medicare paid $93K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93018 Electrocardiogram | Facility | 451 | 449 | $9.79 | $4,415 |
| 93016 Electrocardiogram | Facility | 429 | 427 | $14.83 | $6,361 |
| 78431 Myocardial Perfusion Scan | Facility | 333 | 332 | $60.28 | $20K |
| 93010 Electrocardiogram | Facility | 319 | 298 | $5.97 | $1,905 |
| 78434 Myocardial Perfusion Scan | Facility | 296 | 295 | $20.33 | $6,019 |
| 99214 Office E&M - Established | Office | 259 | 253 | $81.16 | $21K |
| 93000 Electrocardiogram | Office | 229 | 225 | $9.36 | $2,144 |
| 99232 Hospital E&M - Subsequent | Facility | 96 | 66 | $59.44 | $5,707 |
| 99223 Hospital E&M - Initial | Facility | 77 | 74 | $131.69 | $10K |
| 82947 Clinical Chemistry | Office | 60 | 60 | $3.80 | $228 |
| 80061 Clinical Chemistry | Office | 60 | 60 | $12.95 | $777 |
| 78451 Myocardial Perfusion Scan | Facility | 49 | 49 | $41.82 | $2,049 |
| 78452 Myocardial Perfusion Scan | Facility | 47 | 47 | $47.63 | $2,238 |
| 83036 Blood Count | Office | 44 | 44 | $9.52 | $419 |
| 93248 Electrocardiogram | Office | 27 | 27 | $16.41 | $443 |
By year: 2022 $128K for 3,411 services; 2023 $118K for 3,368 services; 2024 $93K for 2,918 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80061 Clinical Chemistry | 60 | 60 | $12.95 | $777 |
| 82947 Clinical Chemistry | 60 | 60 | $3.80 | $228 |
| 83036 Blood Count | 44 | 44 | $9.52 | $419 |
Medicare prescription drug claims, 2024
In 2024, the drug James H O'Keefe Jr. prescribed most often to Medicare patients was Ezetimibe, with 943 prescriptions and refills. In total James H O'Keefe Jr. wrote 8,573 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ezetimibe Generic | 943 | 2,632 | 313 | $21K |
| Atorvastatin Calcium Generic | 862 | 2,450 | 267 | $7,164 |
| Repatha Sureclick Evolocumab | 710 | 1,467 | 184 | $840K |
| Rosuvastatin Calcium Generic | 698 | 1,963 | 231 | $7,808 |
| Carvedilol Generic | 613 | 1,761 | 204 | $4,704 |
| Olmesartan Medoxomil Generic | 415 | 1,148 | 142 | $7,514 |
| Jardiance Empagliflozin | 398 | 841 | 124 | $459K |
| Amlodipine Besylate Generic | 375 | 1,092 | 131 | $2,549 |
| Eliquis Apixaban | 315 | 576 | 81 | $334K |
| Praluent Pen Alirocumab | 215 | 498 | 63 | $260K |
| Ozempic Semaglutide | 174 | 262 | 42 | $250K |
| Metoprolol Succinate Generic | 169 | 488 | 65 | $2,550 |
| Losartan Potassium Generic | 152 | 451 | 52 | $1,530 |
| Lisinopril Generic | 143 | 410 | 54 | $1,228 |
| Spironolactone Generic | 108 | 291 | 34 | $816 |
Brand drugs: - claims; generic drugs: 6,332 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James H O'Keefe Jr. $20K ($20K in general payments such as food, travel and fees) from 3 companies. The largest payer was Amgen Inc. with $17K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.